Co-Authors
This is a "connection" page, showing publications co-authored by David Cole and Brenda Hoffman.
Connection Strength
0.188
-
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res. 2005 Mar 15; 11(6):2205-14.
Score: 0.067
-
Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol. 1997 Dec; 4(8):639-43.
Score: 0.040
-
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
Score: 0.031
-
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer. 2007 Apr 01; 120(7):1511-7.
Score: 0.019
-
Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest. 2005 Feb; 127(2):430-7.
Score: 0.017
-
Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem. 2003 Feb; 49(2):312-5.
Score: 0.014